Stock Market Reviews

PCVX (Vaxcyte, Inc.) News

Get the latest news, insights, and market updates on PCVX (Vaxcyte, Inc.). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Is Vaxcyte, Inc. (PCVX) The Best Stock That Will Bounce Back?
  We recently compiled a list of the 11 Stocks That Will Bounce Back According To Analysts. In this article, we are going to take a look at where Vaxcyte, Inc. (NASDAQ:PCVX) stands against the other stocks that will bounce back. Major US indexes finished in the green on Wednesday, May 7, after a volatile session […]
  May 9, 2025 - $PCVX
• Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
  -- Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 2 Dose-Finding Study of VAX-24 in Healthy Infants; Balance of Data Expected by End of 2025 -- -- Initiated Second and Final Stage of VAX-31 Infant Phase 2 Dose-Finding Study; Topline Safety, Tolerability and Immunogenicity Data from Primary Three-Dose Immunization Series Expected in Mid-2026, With Complete Booster Data Up to Nine Months Later -- -- Company Expects to Initiate VAX-31 Adult Phase 3 Pivotal
  May 7, 2025 - $PCVX
• Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
  SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it has appointed Dr. Olivier Brandicourt, a veteran biopharmaceutical industry executive and the former Chief Executive Officer of Sanofi S.A., to its Board of Directors. “We are thrilled to welcome Olivier to Vaxcyte’s Board of Directors,” said Grant Pickering, Chief Ex
  May 1, 2025 - $PCVX